CELL REGULATION II 1/2
ATI / NCLEX EXAM FOCUS | HIGHLIGHTED LECTURE
# EXAM TOPIC COVERAGE SLIDES
01 Chemotherapy administration PARTIAL 4, 9, 12
Agents are listed; administration precautions are not explained.
02 Endometrial cancer: clinical findings IN DECK 54
Abnormal bleeding, spotting and pelvic pain.
03 Fatigue caused by chemotherapy NOT IN DECK ATI NOTES
Fatigue-management teaching is not explained.
04 Tamoxifen for breast cancer PARTIAL 49
Named as hormonal therapy; monitoring is not discussed.
05 New chest tube: correct function IN DECK 22, 23
Patency, drainage, water-seal fluctuation and air leaks.
06 Complications of radiation therapy PARTIAL 43, 55, 56, 57
Proctitis and internal-radiation precautions appear.
07 Testicular cancer: diagnostics PARTIAL 44
Self-exam and findings; no diagnostic workup.
08 Improvement in a toddler's condition NOT IN DECK ATI NOTES
No specific toddler response-to-treatment scenario.
09 Hodgkin disease: manifestations PARTIAL 61
Hodgkin is named; detailed characteristic findings absent.
10 Complications after prostate surgery IN DECK 42, 43
Infection risk, erectile dysfunction, incontinence, catheter.
11 ALL vs. iron-deficiency anemia PARTIAL 8, 9, 10, 60
ALL findings and anemia appear; no iron-deficiency contrast.
12 Tongue ulcer and oral cancer care IN DECK 24, 25, 26
Mouth lesions, dysphagia, hygiene and post-op care.
13 Tumor lysis syndrome: interventions IN DECK 65, 66, 67, 68, 69, 70
Electrolytes, renal/cardiac risks, hydration and medicines.
14 Neutropenia: client safety PARTIAL 5, 6, 9, 63
Nadir, ANC thresholds, infection warnings; limited details.
Slide numbers are from the original PowerPoint. Select a blue slide number to jump to its first match.
,CELL REGULATION II 2/2
ATI / NCLEX EXAM FOCUS | HIGHLIGHTED LECTURE
# EXAM TOPIC COVERAGE SLIDES
15 Priority findings to address first PARTIAL 23, 65, 69, 74, 75
Selected oncologic and chest-tube emergencies.
16 Self-care for caregivers PARTIAL 62, 63
Parent involvement and referrals, but no self-care plan.
17 Radium / internal radiation implant care IN DECK 55, 56, 57
Time-distance-shielding and displaced implant response.
18 Guardian teaching: diagnostic procedure PARTIAL 9, 62, 63
Bone-marrow aspiration and general guardian education.
19 Stages of death NOT IN DECK ATI NOTES
No stages-of-death framework in this lecture.
20 Traumatic loss: nursing reflection NOT IN DECK ATI NOTES
Grief is named, but no traumatic-loss self-reflection.
21 Differences among code prescriptions NOT IN DECK ATI NOTES
Full code, DNR and other orders are not compared.
22 Dosage calculation: drip rate NOT IN DECK ATI NOTES
No IV drip-rate calculation example.
23 Doxorubicin and cardiotoxicity PARTIAL 9
Doxorubicin is named; cardiac risks are not explained.
24 Chemotherapy nausea: prevention NOT IN DECK ATI NOTES
No specific nausea-reduction teaching.
25 Jackson-Pratt drain management PARTIAL 49, 51, 53
Drain is shown/named; step-by-step emptying absent.
26 Treatment-related infertility options PARTIAL 45
Sperm banking is mentioned; other options are absent.
27 Clarification of code status NOT IN DECK ATI NOTES
No code-status clarification decision scenario.
Slide numbers are from the original PowerPoint. Select a blue slide number to jump to its first match.
,Cellular Regulation II
Holli Benge, MSN, RN
, Leukemias/Lymphomas
Different types of cancers
agenda Oncological emergencies
Survivorship
ATI / NCLEX EXAM FOCUS | HIGHLIGHTED LECTURE
# EXAM TOPIC COVERAGE SLIDES
01 Chemotherapy administration PARTIAL 4, 9, 12
Agents are listed; administration precautions are not explained.
02 Endometrial cancer: clinical findings IN DECK 54
Abnormal bleeding, spotting and pelvic pain.
03 Fatigue caused by chemotherapy NOT IN DECK ATI NOTES
Fatigue-management teaching is not explained.
04 Tamoxifen for breast cancer PARTIAL 49
Named as hormonal therapy; monitoring is not discussed.
05 New chest tube: correct function IN DECK 22, 23
Patency, drainage, water-seal fluctuation and air leaks.
06 Complications of radiation therapy PARTIAL 43, 55, 56, 57
Proctitis and internal-radiation precautions appear.
07 Testicular cancer: diagnostics PARTIAL 44
Self-exam and findings; no diagnostic workup.
08 Improvement in a toddler's condition NOT IN DECK ATI NOTES
No specific toddler response-to-treatment scenario.
09 Hodgkin disease: manifestations PARTIAL 61
Hodgkin is named; detailed characteristic findings absent.
10 Complications after prostate surgery IN DECK 42, 43
Infection risk, erectile dysfunction, incontinence, catheter.
11 ALL vs. iron-deficiency anemia PARTIAL 8, 9, 10, 60
ALL findings and anemia appear; no iron-deficiency contrast.
12 Tongue ulcer and oral cancer care IN DECK 24, 25, 26
Mouth lesions, dysphagia, hygiene and post-op care.
13 Tumor lysis syndrome: interventions IN DECK 65, 66, 67, 68, 69, 70
Electrolytes, renal/cardiac risks, hydration and medicines.
14 Neutropenia: client safety PARTIAL 5, 6, 9, 63
Nadir, ANC thresholds, infection warnings; limited details.
Slide numbers are from the original PowerPoint. Select a blue slide number to jump to its first match.
,CELL REGULATION II 2/2
ATI / NCLEX EXAM FOCUS | HIGHLIGHTED LECTURE
# EXAM TOPIC COVERAGE SLIDES
15 Priority findings to address first PARTIAL 23, 65, 69, 74, 75
Selected oncologic and chest-tube emergencies.
16 Self-care for caregivers PARTIAL 62, 63
Parent involvement and referrals, but no self-care plan.
17 Radium / internal radiation implant care IN DECK 55, 56, 57
Time-distance-shielding and displaced implant response.
18 Guardian teaching: diagnostic procedure PARTIAL 9, 62, 63
Bone-marrow aspiration and general guardian education.
19 Stages of death NOT IN DECK ATI NOTES
No stages-of-death framework in this lecture.
20 Traumatic loss: nursing reflection NOT IN DECK ATI NOTES
Grief is named, but no traumatic-loss self-reflection.
21 Differences among code prescriptions NOT IN DECK ATI NOTES
Full code, DNR and other orders are not compared.
22 Dosage calculation: drip rate NOT IN DECK ATI NOTES
No IV drip-rate calculation example.
23 Doxorubicin and cardiotoxicity PARTIAL 9
Doxorubicin is named; cardiac risks are not explained.
24 Chemotherapy nausea: prevention NOT IN DECK ATI NOTES
No specific nausea-reduction teaching.
25 Jackson-Pratt drain management PARTIAL 49, 51, 53
Drain is shown/named; step-by-step emptying absent.
26 Treatment-related infertility options PARTIAL 45
Sperm banking is mentioned; other options are absent.
27 Clarification of code status NOT IN DECK ATI NOTES
No code-status clarification decision scenario.
Slide numbers are from the original PowerPoint. Select a blue slide number to jump to its first match.
,Cellular Regulation II
Holli Benge, MSN, RN
, Leukemias/Lymphomas
Different types of cancers
agenda Oncological emergencies
Survivorship
